Penumbra PEN
NYSE PEN
$322.02 +0.56 (+0.17%)
As of: Nov 11, 2026 · 11:41 AM EST

Penumbra (PEN) Preferred Stock Liabilities (2014)

Updated

Penumbra (PEN) recorded Preferred Stock Liabilities of $111.47 million in Q4 2014.

Analysis

Penumbra (PEN) Preferred Stock Liabilities (2014) Analysis & Trends

  • Across earlier years, Preferred Stock Liabilities came in at $56.22 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn -
10 Penumbra 12.67 Bn 10.17 Bn 280.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 111.47 Mn
API Access

Penumbra Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PEN&period=max&api_key=YOUR_API_KEY